Get the Stockscreener App
47.22
0.79%
0.37
After Hours:
47.22
Qiagen Nv stock is traded at $47.22, with a volume of 738.15K.
It is up +0.79% in the last 24 hours and up +4.28% over the past month.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).
See More
Previous Close:
$46.85
Open:
$46.86
24h Volume:
738.15K
Relative Volume:
0.57
Market Cap:
$10.16B
Revenue:
$1.98B
Net Income/Loss:
$83.59M
P/E Ratio:
126.26
EPS:
0.374
Net Cash Flow:
$502.31M
1W Performance:
+0.55%
1M Performance:
+4.28%
6M Performance:
+12.48%
1Y Performance:
+4.53%
1-Day Range:
$46.73
$47.51
1-Week Range:
$46.45
$47.93
52-Week Range:
$37.74
$51.88
Qiagen Nv Stock (QGEN) Company Profile
Compare QGEN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
QGEN
Qiagen Nv
|
47.22 | 10.16B | 1.98B | 83.59M | 502.31M | 0.374 |
|
TMO
Thermo Fisher Scientific Inc
|
524.58 | 198.17B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
205.14 | 144.97B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
633.32 | 49.29B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
138.23 | 38.73B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
203.77 | 33.69B | 15.70B | 1.24B | 2.01B | 6.9036 |
Qiagen Nv Stock (QGEN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-24-25 | Initiated | Barclays | Overweight |
| Apr-04-25 | Downgrade | Redburn Atlantic | Buy → Neutral |
| Feb-19-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-06-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-10-24 | Upgrade | Jefferies | Hold → Buy |
| Oct-17-24 | Downgrade | HSBC Securities | Buy → Hold |
| Jun-27-24 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-19-23 | Initiated | Wells Fargo | Equal Weight |
| Dec-13-23 | Initiated | Wolfe Research | Peer Perform |
| Dec-07-23 | Upgrade | Goldman | Neutral → Buy |
| Sep-12-23 | Initiated | Robert W. Baird | Outperform |
| May-23-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Oct-18-22 | Initiated | Morgan Stanley | Equal-Weight |
| Jan-18-22 | Upgrade | DZ Bank | Hold → Buy |
| Oct-15-21 | Resumed | Cowen | Market Perform |
| Oct-14-21 | Initiated | Redburn | Buy |
| Jul-14-21 | Downgrade | Kepler | Buy → Hold |
| Jun-03-21 | Initiated | Goldman | Neutral |
| Oct-06-20 | Resumed | BofA Securities | Buy |
| Sep-28-20 | Upgrade | Kepler | Hold → Buy |
| Aug-24-20 | Upgrade | Citigroup | Neutral → Buy |
| Aug-20-20 | Resumed | JP Morgan | Overweight |
| Aug-17-20 | Upgrade | Berenberg | Hold → Buy |
| Aug-14-20 | Upgrade | Deutsche Bank | Hold → Buy |
| Aug-14-20 | Upgrade | Exane BNP Paribas | Neutral → Outperform |
| Mar-04-20 | Downgrade | Berenberg | Buy → Hold |
| Jan-08-20 | Initiated | Wells Fargo | Equal Weight |
| Jan-07-20 | Initiated | Citigroup | Neutral |
| Dec-26-19 | Resumed | BofA/Merrill | Underperform |
| Nov-15-19 | Initiated | Stifel | Hold |
| Nov-14-19 | Upgrade | Evercore ISI | In-line → Outperform |
| Nov-14-19 | Upgrade | JP Morgan | Underweight → Overweight |
| Nov-14-19 | Upgrade | Kepler | Reduce → Hold |
| Oct-17-19 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Oct-09-19 | Downgrade | Kepler | Hold → Reduce |
| Oct-08-19 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-08-19 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-08-19 | Downgrade | JP Morgan | Neutral → Underweight |
View All
Qiagen Nv Stock (QGEN) Latest News
Using portfolio simulators with Qiagen N.V. included2025 Biggest Moves & Low Risk High Win Rate Picks - newser.com
Leading vs lagging indicators on Qiagen N.V. performancePortfolio Risk Summary & Real-Time Market Trend Scan - newser.com
Is Qiagen N.V. stock a safe haven assetTrade Performance Summary & AI Driven Stock Reports - newser.com
Nov 4 Q3 2025 results release — QIAGEN to issue results Nov 4 (22:05 Frankfurt) and host Nov 5 webcast - Stock Titan
Market reaction to Qiagen N.V.’s recent newsJuly 2025 PreEarnings & Intraday High Probability Setup Alerts - newser.com
Allspring Global Investments Holdings LLC Buys 287,322 Shares of QIAGEN N.V. $QGEN - MarketBeat
What analysts say about Qiagen NV stockPortfolio Diversification Tips & High Profit Trading Alerts - earlytimes.in
Sizing Up Qiagen Shares in 2025 After Recent Earnings Momentum - Yahoo Finance
Vontobel Holding Ltd. Invests $1.59 Million in QIAGEN N.V. $QGEN - MarketBeat
Qiagen N.V. (NYSE:QGEN) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
How cyclical is Qiagen N.V. (QIA) stock compared to rivalsAnalyst Upgrade & Safe Investment Capital Preservation Plans - newser.com
What technical models suggest about Qiagen N.V.’s comeback2025 Performance Recap & AI Forecast Swing Trade Picks - newser.com
Qiagen N.V. stock daily chart insights2025 Stock Rankings & Long-Term Investment Growth Plans - newser.com
Can Qiagen N.V. (QIA) stock deliver consistent EPS growthTrade Ideas & Daily Stock Trend Reports - newser.com
Price action breakdown for Qiagen N.V.New Guidance & High Conviction Investment Ideas - newser.com
Does Qiagen N.V. Common Shares stock trade below intrinsic value2025 Major Catalysts & Technical Entry and Exit Tips - newser.com
Is TPST a good long term investmentMarket Sentiment Extremes & Free High Profit Capital Plays - earlytimes.in
Qiagen (NYSE:QGEN) Earns Hold (C+) Rating from Weiss Ratings - MarketBeat
OLD National Bancorp IN Buys Shares of 5,277 QIAGEN N.V. $QGEN - MarketBeat
Is Qiagen NV a good long term investmentReal-Time Stock Alerts & Breakthrough Investment Results - earlytimes.in
Qiagen N.V. Announces Voting Rights Notification by AFM - TipRanks
PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - TradingView
What dividend safety score for Qiagen N.V. stockEarnings Miss & Weekly Watchlist of Top Performers - newser.com
How Qiagen N.V. stock reacts to oil pricesJuly 2025 Recap & Capital Efficient Trade Techniques - newser.com
Clifford Chance advises international banking syndicate on $750 million convertible bond issuance of QIAGEN N.V. - Legal Desire Media and Insights
Can Qiagen N.V. (QIA) stock deliver double digit returnsGap Down & Stock Timing and Entry Methods - newser.com
Will Qiagen N.V. stock attract more institutional investorsBond Market & Reliable Price Breakout Signals - newser.com
Will Qiagen N.V. price bounce be sustainableJuly 2025 Catalysts & Safe Investment Capital Preservation Plans - newser.com
Why Qiagen (QGEN) Is Up 6.6% After FDA Clearance and Raised Sales Guidance - Sahm
Why Qiagen N.V. (QIA) stock appears on watchlistsRate Hike & AI Driven Stock Reports - newser.com
How Qiagen N.V. Common Shares stock trades after rate cutsJuly 2025 Short Interest & Weekly Chart Analysis and Guides - newser.com
J. Safra Sarasin Holding AG Purchases Shares of 7,011 QIAGEN N.V. $QGEN - MarketBeat
What Qiagen N.V.'s (NYSE:QGEN) P/S Is Not Telling You - 富途牛牛
111 Capital Purchases Shares of 47,321 Qiagen N.V. $QGEN - MarketBeat
QGEN Collaborates With McGill University Centre: Stock to Gain? - MSN
QIAGEN (NYSE:QGEN) Stock Rating Lowered by Wall Street Zen - MarketBeat
QIAGEN Receives Several Conditional, Non-binding Indications of Interest, Enters Into Discussions to Explore Potential Strate... - ADVFN
How geopolitical risks impact Qiagen N.V. Common Shares stockMarket Movement Recap & Safe Entry Momentum Tips - newser.com
Statistical indicators supporting Qiagen N.V.’s strength2025 Volatility Report & Growth Focused Entry Point Reports - newser.com
Qiagen Nv Stock (QGEN) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.61%
0.70%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):